Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis
Kyung Su Kim, Jeanny Kwon, Kyubo Kim, Eui Kyu Chie
Cancer Res Treat. 2017;49(3):824-833.   Published online 2016 Aug 26     DOI: https://doi.org/10.4143/crt.2016.336
Citations to this article as recorded by Crossref logo
Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenocarcinoma
Vincent Dunet, Nermin Halkic, Christine Sempoux, Nicolas Demartines, Michael Montemurro, John O. Prior, Sabine Schmidt
European Radiology.2021; 31(2): 992.     CrossRef
First report on the feasibility of a permanently implantable uni-directional planar low dose rate brachytherapy sheet for patients with resectable or borderline resectable pancreatic cancer
Joshua B. Dault, Dorin Todor, Brian J. Kaplan, Jennifer L. Myers, Emma C. Fields
Brachytherapy.2021; 20(1): 207.     CrossRef
Periarterial divestment in pancreatic cancer surgery
Markus K. Diener, André L. Mihaljevic, Oliver Strobel, Martin Loos, Thomas Schmidt, Martin Schneider, Christoph Berchtold, Arianeb Mehrabi, Beat P. Müller-Stich, Kuirong Jiang, John P. Neoptolemos, Thilo Hackert, Yi Miao, Markus W. Büchler
Surgery.2021; 169(5): 1019.     CrossRef
R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma
Stefano Crippa, Fabio Giannone, Marco Schiavo Lena, Giulio Belfiori, Stefano Partelli, Domenico Tamburrino, Roberto Delpini, Michele Pagnanelli, Nicolo Pecorelli, Gianpaolo Balzano, Claudio Doglioni, Massimo Falconi
Annals of Surgical Oncology.2021;[Epub]     CrossRef
Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy
Ryan K. Schmocker, Daniel Delitto, Michael J. Wright, Ding Ding, John L. Cameron, Kelly J. Lafaro, William R. Burns, Christopher L. Wolfgang, Richard A. Burkhart, Jin He
Journal of the American College of Surgeons.2021; 232(4): 405.     CrossRef
A Novel DNA Replication-Related Signature Predicting Recurrence After R0 Resection of Pancreatic Ductal Adenocarcinoma: Prognostic Value and Clinical Implications
Zengyu Feng, Kexian Li, Jianyao Lou, Mindi Ma, Yulian Wu, Chenghong Peng
Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
Impact of resection margin status on survival in advanced N stage pancreatic cancer – a multi-institutional analysis
Christian Teske, Richard Stimpel, Marius Distler, Susanne Merkel, Robert Grützmann, Louisa Bolm, Ulrich Wellner, Tobias Keck, Daniela E. Aust, Jürgen Weitz, Thilo Welsch
Langenbeck's Archives of Surgery.2021;[Epub]     CrossRef
Radical antegrade modular pancreatosplenectomy (RAMPS) versus conventional distal pancreatectomy for left-sided pancreatic cancer: findings of a multicenter, retrospective, propensity score matching study
Hyung Sun Kim, Tae Ho Hong, Young-Kyoung You, Joon Seong Park, Dong Sup Yoon
Surgery Today.2021;[Epub]     CrossRef
What do surgeons need to know about the mesopancreas
Eduardo de Souza M. Fernandes, Oliver Strobel, Camila Girão, Jose Maria A. Moraes-Junior, Orlando Jorge M. Torres
Langenbeck's Archives of Surgery.2021;[Epub]     CrossRef
Recurrence patterns of pancreatic cancer after pancreatoduodenectomy: systematic review and a single-centre retrospective study
Marit Kalisvaart, Damian Broadhurst, Francesca Marcon, Rupaly Pande, Andrea Schlegel, Robert Sutcliffe, Ravi Marudanayagam, Darius Mirza, Nikolaos Chatzizacharias, Manuel Abradelo, Paolo Muiesan, John Isaac, Yuk T. Ma, Christopher McConville, Keith Robert
HPB.2020; 22(9): 1240.     CrossRef
Positive neck margin at frozen section analysis is a significant predictor of tumour recurrence and poor survival after pancreatodudenectomy for pancreatic cancer
Stefano Crippa, Giovanni Guarneri, Giulio Belfiori, Stefano Partelli, Michele Pagnanelli, Giulia Gasparini, Gianpaolo Balzano, Marco Schiavo Lena, Corrado Rubini, Claudio Doglioni, Giuseppe Zamboni, Massimo Falconi
European Journal of Surgical Oncology.2020; 46(8): 1524.     CrossRef
Resection or repair of large peripancreatic arteries during robotic pancreatectomy
Emanuele F. Kauffmann, Niccolò Napoli, Concetta Cacace, Francesca Menonna, Fabio Vistoli, Gabriella Amorese, Ugo Boggi
Updates in Surgery.2020; 72(1): 145.     CrossRef
In the Era of the Leeds Protocol: A Systematic Review and A Meta-Analysis on the Effect of Resection Margins on Survival Among Pancreatic Ductal Adenocarcinoma Patients
B. Kurlinkus, R. Ahola, E. Zwart, A. Halimi, B. S. Yilmaz, G. O. Ceyhan, J. Laukkarinen
Scandinavian Journal of Surgery.2020; 109(1): 11.     CrossRef
Systematic Analysis of Accuracy in Predicting Complete Oncological Resection in Pancreatic Cancer Patients—Proposal of a New Simplified Borderline Resectability Definition
Louisa Bolm, Katharina Mueller, Katharina May, Stefan Sondermann, Ekaterina Petrova, Hryhoriy Lapshyn, Kim Christin Honselmann, Dirk Bausch, Sergii Zemskov, Peter Bronsert, Tobias Keck, Steffen Deichmann, Ulrich F. Wellner
Cancers.2020; 12(4): 882.     CrossRef
Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study
Hongcheng Wang, Jiazhe Liu, Guanggai Xia, Shizhou Lei, Xiuyan Huang, Xinyu Huang
Scientific Reports.2020;[Epub]     CrossRef
Circumferential resection margin (CRM) in pancreatic cancer
Lena Häberle, Irene Esposito
Surgery in Practice and Science.2020; 1: 100006.     CrossRef
Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma
Tsengelmaa Jamiyan, Takayuki Shiraki, Yoshihiro Kurata, Masanori Ichinose, Keiichi Kubota, Yasuo Imai
World Journal of Surgical Oncology.2020;[Epub]     CrossRef
Prognostic Implications of 18-FDG Positron Emission Tomography/Computed Tomography in Resectable Pancreatic Cancer
Cosimo Sperti, Alberto Friziero, Simone Serafini, Sergio Bissoli, Alberto Ponzoni, Andrea Grego, Emanuele Grego, Lucia Moletta
Journal of Clinical Medicine.2020; 9(7): 2169.     CrossRef
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Aaron J. Grossberg, Linda C. Chu, Christopher R. Deig, Eliot K. Fishman, William L. Hwang, Anirban Maitra, Daniel L. Marks, Arnav Mehta, Nima Nabavizadeh, Diane M. Simeone, Colin D. Weekes, Charles R. Thomas
CA: A Cancer Journal for Clinicians.2020; 70(5): 375.     CrossRef
Survival benefit of adjuvant chemoradiotherapy for positive or close resection margin after curative resection of pancreatic adenocarcinoma
Byoung Hyuck Kim, Kyubo Kim, Jin-Young Jang, Wooil Kwon, Hongbeom Kim, Kyung-Hun Lee, Do-Youn Oh, Haeryoung Kim, Kyung Bun Lee, Eui Kyu Chie
European Journal of Surgical Oncology.2020; 46(11): 2122.     CrossRef
Pre‐operative diabetes mellitus does not worsen survival and post‐operative outcomes in C hinese patients undergoing resection for pancreatic adenocarcinoma
Adrian H. K. Yu, Albert C. Y. Chan
Surgical Practice.2020; 24(4): 132.     CrossRef
Advances and challenges of neoadjuvant therapy in pancreatic cancer
Yang Yu, Peng Zheng, Yajing Chen, Bofang Wang, Maswikiti Ewetse Paul, Pengxian Tao, Dengfeng Wang, Haiyuan Li, Baohong Gu, Lei Gao, Dan Wang, Hao Chen
Asia-Pacific Journal of Clinical Oncology.2020;[Epub]     CrossRef
Multiagent neoadjuvant chemotherapy and tumor response are associated with improved survival in pancreatic cancer
Nathan M. Bolton, Adam H. Maerz, Russell E. Brown, Mona Bansal, John S. Bolton, William C. Conway
HPB.2019; 21(4): 413.     CrossRef
The learning curve for a surgeon in robot-assisted laparoscopic pancreaticoduodenectomy: a retrospective study in a high-volume pancreatic center
Tao Zhang, Zhi-Ming Zhao, Yuan-Xing Gao, Wan Yee Lau, Rong Liu
Surgical Endoscopy.2019; 33(9): 2927.     CrossRef
Selecting chemotherapy for pancreatic cancer: Far away or so close?
Si Shi, Xianjun Yu
Seminars in Oncology.2019; 46(1): 39.     CrossRef
Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I‐II pancreatic cancer
Sung Jun Ma, Gregory M. Hermann, Kavitha M. Prezzano, Lucas M. Serra, Austin J. Iovoli, Anurag K. Singh
Cancer Medicine.2019; 8(3): 939.     CrossRef
Duktales Adenokarzinom des Pankreas
E. Gallmeier, T. M. Gress
Der Gastroenterologe.2019; 14(2): 131.     CrossRef
Management of pancreatic head adenocarcinoma: From where to where?
Kemal Dolay, Fatma Umit Malya, Sami Akbulut
World Journal of Gastrointestinal Surgery.2019; 11(3): 143.     CrossRef
Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma
Vincent P. Groot, Georgios Gemenetzis, Alex B. Blair, Roberto J. Rivero-Soto, Jun Yu, Ammar A. Javed, Richard A. Burkhart, Inne H. M. Borel Rinkes, I. Quintus Molenaar, John L. Cameron, Matthew J. Weiss, Christopher L. Wolfgang, Jin He
Annals of Surgery.2019; 269(6): 1154.     CrossRef
A Prospective Clinical Trial to Determine the Effect of Intraoperative Ultrasound on Surgical Strategy and Resection Outcome in Patients with Pancreatic Cancer
Babs G. Sibinga Mulder, Shirin Feshtali, Arantza Fariña Sarasqueta, Alexander L. Vahrmeijer, Rutger-Jan Swijnenburg, Bert A. Bonsing, J. Sven D. Mieog
Ultrasound in Medicine & Biology.2019; 45(8): 2019.     CrossRef
Microvascular invasion is a major prognostic factor after pancreatico‐duodenectomy for adenocarcinoma
Fabrizio Panaro, Tarek Kellil, Julie Vendrell, Valentina Sega, Regis Souche, Tullio Piardi, Piera Leon, Christophe Cassinotto, Eric Assenat, Edoardo Rosso, Francis Navarro
Journal of Surgical Oncology.2019; 120(3): 483.     CrossRef
Role of surgical resection in the era of FOLFIRINOX for advanced pancreatic cancer
Yoonhyeong Byun, Youngmin Han, Jae Seung Kang, Yoo Jin Choi, Hongbeom Kim, Wooil Kwon, Sun‐Whe Kim, Do‐Youn Oh, Sang Hyub Lee, Ji Kon Ryu, Yong‐Tae Kim, Jin‐Young Jang
Journal of Hepato-Biliary-Pancreatic Sciences.2019; 26(9): 416.     CrossRef
Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer
Lucia Roa-Peña, Cindy V. Leiton, Sruthi Babu, Chun-Hao Pan, Elizabeth A. Vanner, Ali Akalin, Jela Bandovic, Richard A. Moffitt, Kenneth R. Shroyer, Luisa F. Escobar-Hoyos
Scientific Reports.2019;[Epub]     CrossRef
Comment on “The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma”
Niccolo Petrucciani, Laura Antolino, Giovanni Moschetta, Giovanni Ramacciato
Annals of Surgery.2019; 270(6): e129.     CrossRef
Determining Optimal Routes to Surgery for Borderline Resectable Venous Pancreatic Cancer—Where Is the Least Harm and Most Benefit?
Rupaly Pandé, Keith J. Roberts
Frontiers in Oncology.2019;[Epub]     CrossRef
Duktales Adenokarzinom des Pankreas
E. Gallmeier, T. M. Gress
Der Internist.2018; 59(8): 805.     CrossRef
Adjuvant Chemotherapy Versus Chemoradiation for Patients with Resected Pancreatic Adenocarcinoma: A Single-Center Retrospective Study
Do Young Kim, Young Jin Choi, Young Mi Seol, Hyojeong Kim
The Korean Journal of Pancreas and Biliary Tract.2018; 23(3): 108.     CrossRef
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
Andrew McGuigan, Paul Kelly, Richard C Turkington, Claire Jones, Helen G Coleman, R Stephen McCain
World Journal of Gastroenterology.2018; 24(43): 4846.     CrossRef
Combined hepatic arterial resection in pancreatic resections for locally advanced pancreatic cancer
Masaru Miyazaki, Hideyuki Yoshitomi, Shigetsugu Takano, Hiroaki Shimizu, Atsushi Kato, Hiroyuki Yoshidome, Katunori Furukawa, Tsukasa Takayashiki, Satoshi Kuboki, Daisuke Suzuki, Nozomu Sakai, Masayuki Ohtuka
Langenbeck's Archives of Surgery.2017; 402(3): 447.     CrossRef
The TRIANGLE operation – radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study
Thilo Hackert, Oliver Strobel, Christoph W. Michalski, André L. Mihaljevic, Arianeb Mehrabi, Beat Müller-Stich, Christoph Berchtold, Alexis Ulrich, Markus W. Büchler
HPB.2017; 19(11): 1001.     CrossRef